Gelnova

Mumbai, India Founded: 2002 • Age: 24 yrs
Manufacturing of Soft Gelatin Capsules and Lozenges for pharmaceutical applications in India.

About Gelnova

Gelnova is a Healthcare company based in Mumbai (India) founded in 2002. Manufacturing of Soft Gelatin Capsules and Lozenges for pharmaceutical applications in India. The company has 82 employees. Its Indian entity Gelnova Laboratories (India) Private Limited reported revenue of β‚Ή61.38 Cr. Gelnova offers products and services including Soft Gelatin Capsules and Lozenges. Its focus areas include Research and Development, Innovation, Soft Gelatin Technology and Pharmaceuticals.

Company details

Gelnova Laboratories Pvt. Ltd. was established in 2002 in Navi Mumbai, India, and is engaged in the manufacturing of Soft Gelatin Capsules and Lozenges for pharmaceutical purposes. A manufacturing area of 1614.2 m2 and a storage area of 855.36 m2 are utilized by the company. Research and Development is directed towards innovations in Soft Gelatin technology, while the facility is maintained as WHO compliant and approved by global regulatory bodies. Patents for Nicotine Pastilles are held by the company, reflecting its contributions to the field.

Key Metrics
  • Annual Revenue
    ₹61.38 Cr

    FY 2025 · -4% YoY

  • Net Profit
    ₹77.7 Lakh

    FY 2025 · 1% margin

  • EBITDA
    ₹4.29 Cr

    FY 2025 · 7% margin

  • Employee Count
    82

Products & Services of Gelnova

Gelnova offers a comprehensive portfolio of products and services, including Soft Gelatin Capsules and Lozenges.

Soft Gelatin Capsules
Pharmaceutical Products

Soft Gelatin Capsules are manufactured for pharmaceutical applications.

Lozenges
Pharmaceutical Products

Lozenges are produced for pharmaceutical uses.

Board of directors of Gelnova Laboratories (India) Private Limited (Gelnova)

Gelnova Laboratories (India) Private Limited is the primary company behind Gelnova. The board of Gelnova Laboratories (India) Private Limited currently have 3 directors; the longest-serving is Bharati Vasant Thakkar, appointed in 2000. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Bharati Vasant Thakkar
DIN 00080070
Director18 Aug 200026 yrs 2 moGelnova Laboratories (India) Private Limited
Dhananjay Thakorbhai Desai
DIN 00049574
Director15 Oct 200917 yrsGelnova Laboratories (India) Private Limited
Jatin Vasant Thakkar
DIN 00079977
Managing Director30 Sep 201511 yrs 1 moGelnova Laboratories (India) Private Limited

Financials of Gelnova

Figures of Gelnova Laboratories (India) Private Limited, the primary company behind Gelnova, for FY 2025. Revenue was ₹61.38 Cr (-4% year on year). Net profit was ₹77.7 Lakh (1% margin). EBITDA was ₹4.29 Cr (7% margin). Revenue has grown at a compounded annual rate of +5% over three years and +6% over five years.

  • ₹61.38 CrRevenue · FY 2025 · -4% YoY
  • ₹77.7 LakhNet profit · 1% margin
  • ₹4.29 CrEBITDA · 7% margin
  • ₹1.30 CrPaid-up capital
  • 82Employees (provident fund records)
  • +5%Revenue CAGR, 3 years
  • +6%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Gelnova Laboratories (India) Private Limited are on its company page.

Premium access

Detailed financial statements for Gelnova

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Top companies in Clinical Trials & Research Tech

2 companies that operate in the same segment as Gelnova (Clinical Trials & Research Tech) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare.
2004Ahmedabad, Gujarat, IndiaUSD 50.52 M902
Generic injectables for oncology and anesthesiology are manufactured.
1989Hyderabad, Telangana, IndiaUSD 4.22 M228
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Gelnova

Gelnova was founded in 2002.

Gelnova is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Gelnova has 82 employees.

The primary company behind Gelnova, Gelnova Laboratories (India) Private Limited, reported revenue of β‚Ή61.38 Cr for FY 2025, down 4% year on year.

Gelnova Laboratories Pvt. Ltd. was established in 2002 in Navi Mumbai, India, and is engaged in the manufacturing of Soft Gelatin Capsules and Lozenges for pharmaceutical purposes. A manufacturing area of 1614.2 m2 and a storage area of 855.36 m2 are utilized by the company. Research and Development is directed towards innovations in Soft Gelatin technology, while the facility is maintained as WHO compliant and approved by global regulatory bodies. Patents for Nicotine Pastilles are held by the company, reflecting its contributions to the field.

Gelnova offers Soft Gelatin Capsules and Lozenges.

Gelnova operates through Gelnova Laboratories (India) Private Limited.

The legal entities of Gelnova currently have 3 directors, including Bharati Vasant Thakkar, Jatin Vasant Thakkar, Dhananjay Thakorbhai Desai.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available